Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Oncology and Therapy
|
September 14, 2025
Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST Study
Benoît Godbert, Elisa Gobbini, Chantal Decroisette, et al.
Journal of Clinical Pathology
|
June 7, 2015
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer
Umberto Malapelle, Simona Vatrano, Stefania Russo, et al.
Nature Communications
|
March 29, 2025
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
Candice Sakref, Alexis Saby, Céline Rodriguez, et al.
Clinical Lung Cancer
|
November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer
Elisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Science Immunology
|
April 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Margaux Hubert, Elisa Gobbini, Coline Couillault, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 23, 2025
The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapy
Caroline Plazy, Mohamed Boussena, Linh Nguyen Phuong, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 22, 2025
Clinical characteristics and management of long survivors in extensive stage small cell lung cancer
Elisa Gobbini, Mamadou Hassimiou Diallo, David Pasquier, et al.
European Journal of Immunology
|
January 9, 2023
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods
Felix Bayerl, David A Bejarano, Giulia Bertacchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 18, 2025
Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS
Elisa Gobbini, Alexandra Langlais, Pascale Missy, et al.
Cancer Immunology Research
|
January 8, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma
Elisa Gobbini, Margaux Hubert, Anne-Claire Doffin, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Oncology and Therapy
|
September 14, 2025
Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST Study
Benoît Godbert, Elisa Gobbini, Chantal Decroisette, et al.
Journal of Clinical Pathology
|
June 7, 2015
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer
Umberto Malapelle, Simona Vatrano, Stefania Russo, et al.
Nature Communications
|
March 29, 2025
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2
Candice Sakref, Alexis Saby, Céline Rodriguez, et al.
Clinical Lung Cancer
|
November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer
Elisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Science Immunology
|
April 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Margaux Hubert, Elisa Gobbini, Coline Couillault, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 23, 2025
The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapy
Caroline Plazy, Mohamed Boussena, Linh Nguyen Phuong, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 22, 2025
Clinical characteristics and management of long survivors in extensive stage small cell lung cancer
Elisa Gobbini, Mamadou Hassimiou Diallo, David Pasquier, et al.
European Journal of Immunology
|
January 9, 2023
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods
Felix Bayerl, David A Bejarano, Giulia Bertacchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 18, 2025
Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS
Elisa Gobbini, Alexandra Langlais, Pascale Missy, et al.
Cancer Immunology Research
|
January 8, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma
Elisa Gobbini, Margaux Hubert, Anne-Claire Doffin, et al.
Page
of 5